You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative Disorders

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Philadelphia Negative Myeloproliferative Tumors Trial

Not yet recruiting
  • Philadelphia Negative Myeloproliferative Neoplasms
    • (no location specified)
    Jun 5, 2022

    Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • sargramostim
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 3, 2022

    Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

    Not yet recruiting
    • Leukemia, Acute
    • +7 more
    • (no location specified)
    Apr 10, 2023

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

    Not yet recruiting
    • Myeloproliferative Disorders
    • Lymphoproliferative Disorders
    • Blood collection for the evaluation of the anti-drugs sensitivity
    • Pierre-Bénite, France
    • +1 more
    Mar 2, 2022

    Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Fedratinib Pill
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 15, 2022

    Myeloproliferative Tumor Trial in Irvine (Diet intervention)

    Completed
    • Myeloproliferative Neoplasm
    • Diet intervention
    • Irvine, California
      University of California, Irvine
    Jun 16, 2022

    MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 16, 2023

    Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 12, 2022

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    National Center for Precision Medicine in Leukemia

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Biobanking
    • (no location specified)
    Jun 7, 2022

    MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Stockholm, Sweden
      Department of Hematology, Karolinska University Hospital
    Mar 27, 2023

    Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Peptide-based vaccine
    • Poly ICLC
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 7, 2022

    Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • CIML NK
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jan 6, 2023

    Thrombotic Complications (CLOJAK)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Blood sampling
    • Angers, France
    • +10 more
    Apr 20, 2023

    ph Negative Myeloproliferative Neoplasms: Impact on Outcome and

    Recruiting
    • Myeloproliferative Disease
    • Inflammatory Markers
      • Bari, Italy
      • +10 more
      Oct 21, 2022

      Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

      Recruiting
      • Acute Myeloid Leukemia
      • +8 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 18, 2022

      Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • +4 more
      • Biospecimen Collection
      • +6 more
      • Los Angeles, California
      • +1 more
      Oct 4, 2023

      Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

      Enrolling by invitation
      • Myelodysplastic/Myeloproliferative Neoplasms
      • Adult
      • venetoclax combined with azacitidine
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University, Jiangsu Ins
      Mar 7, 2022

      Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

      Completed
      Has Results
      • Myeloproliferative Disorders
      • +4 more
      • T-cell replete PBPC allograft
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 12, 2022

      Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,

      Completed
      Has Results
      • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 18, 2022

      Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Recombinant Interleukin-7
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 26, 2023

      Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

      Recruiting
      • Brain and Central Nervous System Tumors
      • +8 more
      • 3'-deoxy-3'-[18F]fluorothymidine
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Mar 30, 2022

      Intravenous Busulfan And Fludarabine Myeloablative Conditioning

      Completed
      • Acute Myeloid Leukemia
      • +3 more
        • (no location specified)
        Mar 16, 2022

        Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis

        Active, not recruiting
        • Myeloproliferative Neoplasm
        • +3 more
        • standard of care.
        • (no location specified)
        Sep 14, 2021